(Q80845729)
Statements
Treatment with anti-MHC-class-II antibody postpones kidney allograft rejection in primates but increases the risk of CMV activation (English)
Jan Ringers
Eva-Maria Kuhn
Bert 't Hart
1 reference
scientific article published on 01 November 2004